Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 1:14 AM
NCT ID:
NCT07278193
Eligibility Criteria:
Inclusion Criteria:
* Age 35-50 years diagnosed with Piriformis Syndrome based on clinical findings. (Chang et al., 2024)
* Having positive FAIR test is commonly used to diagnose piriformis syndrome.
* Pain intensity of at least 4 on the numeric pain rating scale (NPRS) at baseline(A Penichet-Tomas et al., 2021).
DIAGNOSTIC CRITERIA OF PIRIFORMIS SYNDROME
The diagnostic criteria for piriformis syndrome include clinical history, physical examination findings. The symptoms include buttock pain radiating to the posterior thigh or leg, worsened by sitting, climbing stairs, or activities that stretch the piriformis muscle. Physical examination, tenderness over the piriformis muscle or sciatic notch and a positive FAIR test (Flexion, Adduction, and Internal Rotation) are indicative. Additional tests, such as the Pace test and Straight Leg Raise with external rotation.
Exclusion Criteria:
* Current use of medications such as strong analgesics or muscle relaxants. (e.g., injections, surgery) within the last three months.
* Uncontrolled medical conditions, such as active infections, cancer, or cardiovascular issues that may interfere with the study or the participant's ability to complete the protocol safely(Alfonso Penichet-Tomas et al., 2021).
* History of lumbar disc herniation, spinal stenosis, or other serious lumbar spine pathologies that may cause similar symptoms.
* Prior surgeries in the lumbar spine, hip, or pelvis that may interfere with the study's outcomes(Pişirici et al., 2020).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
50 Years
Study:
NCT07278193
Study Brief:
Protocol Section:
NCT07278193